Summary of ALLOS THERAPEUTICS INC

Search - Finance Home - Yahoo! - Help

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

ALTH > SEC Filings for ALTH > Form 8-K on 8-Dec-2009

All Recent SEC Filings

Show all filings for ALLOS THERAPEUTICS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ALLOS THERAPEUTICS INC

8-Dec-2009

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.

On December 8, 2009, Allos Therapeutics, Inc. issued a press release announcing updated data from its ongoing dose finding Phase 1 study of FOLOTYN™ (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma. The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1   Press Release, dated December 8, 2009, entitled "Allos Therapeutics'
       FOLOTYN™ Shows Activity in a Dose Finding Phase 1 Study of Relapsed or
       Refractory Cutaneous T-cell Lymphoma."

Add ALTH to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for ALTH - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.